Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Revenue (2023 - 2025)

Historic Revenue for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $5.3 million.

  • Profound Medical's Revenue rose 8675.85% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 6794.31%. This contributed to the annual value of $10.7 million for FY2024, which is 4835.39% up from last year.
  • As of Q3 2025, Profound Medical's Revenue stood at $5.3 million, which was up 8675.85% from $2.2 million recorded in Q2 2025.
  • Profound Medical's Revenue's 5-year high stood at $5.3 million during Q3 2025, with a 5-year trough of $1.4 million in Q1 2024.
  • In the last 3 years, Profound Medical's Revenue had a median value of $2.2 million in 2025 and averaged $2.5 million.
  • The largest annual percentage gain for Profound Medical's Revenue in the last 5 years was 10786.46% (2024), contrasted with its biggest fall of 2263.44% (2024).
  • Profound Medical's Revenue (Quarter) stood at $2.0 million in 2023, then soared by 107.86% to $4.2 million in 2024, then rose by 26.65% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $2.2 million for Q2 2025, and $2.6 million during Q1 2025.